Jeffrey Stevens

Psyched Wellness Ltd (OTCQB: PSYCF) plans to begin selling a psychoactive mushroom extract this summer that’s never been scheduled as a drug in the U.S. It’s derived from amanita muscaria, an instantly recognizable, red-capped fungi, and its active ingredient muscimol. “Everyone...

Jeffrey Stevens, the CEO and co-founder of Psyched Wellness (OTCQB: PSYCF), has bought 321,000 shares of the company in the open market at CA$0.125 per share for a total cost of of CA$40,125 (around $31,750). “Our stock price has increased in the last quarter alone. In addition to...